Abstract

Rapid detection and phenotyping of pathogenic microbes is critical for administration of effective antibiotic therapies and for impeding the spread of antibiotic resistance. Here, we present a novel platform, rapid ultrasensitive detector (RUSD), that utilizes the high reflectance coefficient at high incidence angles when light travels from low- to high-refractive-index media. RUSD leverages a principle that does not require complex manufacturing, labeling, or processing steps. Utilizing RUSD, we can detect extremely low cell densities (optical density [OD] ≥ 5 × 10−7) that correspond to approximately 20 bacterial cells or a single fungal cell in the detection volume, which is nearly 4 orders of magnitude more sensitive than standard OD methods. RUSD can measure minimum inhibitory concentrations (MICs) of commonly used antibiotics against gram-negative and gram-positive bacteria, including Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli, within 2 to 4 h. Here, we demonstrate that antibiotic susceptibility tests for several pathogens can rapidly be performed with RUSD using both small inoculum sizes (500 cells/mL) and larger inoculum sizes (5 × 105 cells/mL) used in standard antibiotic susceptibility tests. We anticipate that the RUSD system will be particularly useful for the cases in which antibiotic susceptibility tests have to be done with a limited number of bacterial cells that are available. Its compatibility with standard antibiotic susceptibility tests, simplicity, and low cost can make RUSD a viable and rapidly deployed diagnostic tool.

Highlights

  • Optimal treatment of infectious diseases requires early detection of pathogenic microbes [1]

  • The Rapid ultrasensitive detection (RUSD) platform is a rapid, label-free, highly sensitive, and low-cost optical detection system that could be used as a field-deployable device

  • The use of RUSD will be advantageous in cases for which the number of bacterial cells available are limited

Read more

Summary

Introduction

Optimal treatment of infectious diseases requires early detection of pathogenic microbes [1]. Despite advances in medical technology, both detection and characterization of pathogenic microbes can still take up to several days [2,3,4]. Clinicians are relegated to starting empiric antibiotic therapies that are typically broad in coverage and may have deleterious sequelae such as inducing gut microbiome dysbiosis and potentially exacerbating the ongoing. Rapid ultrasensitive detection (RUSD) platform for antimicrobial susceptibility testing study design, data collection and analysis, decision to publish, or preparation of the manuscript

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call